Outlining	O
a	O
Population	B:C0242444
"	I:C0242444
at	I:C0242444
Risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
:	O
Evidence	O
from	O
a	O
Case	O
-	I:C0007328
Control	I:C0007328
Study	I:C0007328
.	O

Outlining	O
a	O
Population	O
"	I:C0242444
at	I:C0242444
Risk	I:C0242444
"	I:C0242444
of	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
:	O
Evidence	O
from	O
a	O
Case	O
-	I:C0007328
Control	I:C0007328
Study	I:C0007328
.	O

Outlining	O
a	O
Population	O
"	I:C0242444
at	I:C0242444
Risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
:	O
Evidence	O
from	O
a	O
Case	B:C0007328
-	I:C0007328
Control	I:C0007328
Study	I:C0007328
.	O

The	O
multifactorial	B:C0699748
pathogenesis	I:C0699748
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
)	O
requires	O
a	O
careful	O
identification	O
of	O
populations	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
developing	O
the	O
disease	O
.	O

The	O
multifactorial	O
pathogenesis	I:C0699748
of	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
)	O
requires	O
a	O
careful	O
identification	O
of	O
populations	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
developing	O
the	O
disease	O
.	O

The	O
multifactorial	O
pathogenesis	I:C0699748
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
(	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
)	O
requires	O
a	O
careful	O
identification	O
of	O
populations	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
developing	O
the	O
disease	O
.	O

The	O
multifactorial	O
pathogenesis	I:C0699748
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
)	O
requires	O
a	O
careful	O
identification	O
of	O
populations	B:C0242444
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
developing	O
the	O
disease	O
.	O

The	O
multifactorial	O
pathogenesis	I:C0699748
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
)	O
requires	O
a	O
careful	O
identification	O
of	O
populations	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
developing	O
the	O
disease	B:C0030567
.	O

In	O
this	O
case	B:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
we	O
analyzed	O
a	O
large	O
Italian	O
population	O
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

In	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
we	O
analyzed	B:C0936012
a	O
large	O
Italian	O
population	O
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

In	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
we	O
analyzed	O
a	O
large	O
Italian	B:C0022277
population	O
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

In	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
we	O
analyzed	O
a	O
large	O
Italian	O
population	B:C1257890
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

In	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
we	O
analyzed	O
a	O
large	O
Italian	O
population	O
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	B:C0242444
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

In	O
this	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
we	O
analyzed	O
a	O
large	O
Italian	O
population	O
,	O
in	O
an	O
attempt	O
to	O
outline	O
general	O
criteria	O
to	O
define	O
a	O
population	O
"	I:C0242444
at	I:C0242444
risk	I:C0242444
"	I:C0242444
of	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
.	O

We	O
enrolled	O
300	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
patients	O
and	O
300	O
controls	O
,	O
gender	O
and	O
age	O
matched	O
,	O
from	O
the	O
same	O
urban	O
geographical	O
area	O
.	O

All	O
subjects	B:C0080105
were	O
interviewed	O
on	O
demographics	O
,	O
family	O
history	I:C0241889
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
,	O
occupational	O
and	O
environmental	O
toxicants	O
exposure	O
,	O
smoking	O
status	I:C1519386
,	O
and	O
alcohol	O
consumption	O
.	O

All	O
subjects	O
were	O
interviewed	O
on	O
demographics	O
,	O
family	B:C0241889
history	I:C0241889
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
,	O
occupational	O
and	O
environmental	O
toxicants	O
exposure	O
,	O
smoking	O
status	I:C1519386
,	O
and	O
alcohol	O
consumption	O
.	O

All	O
subjects	O
were	O
interviewed	O
on	O
demographics	O
,	O
family	O
history	I:C0241889
of	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
,	O
occupational	O
and	O
environmental	O
toxicants	O
exposure	O
,	O
smoking	O
status	I:C1519386
,	O
and	O
alcohol	O
consumption	O
.	O

All	O
subjects	O
were	O
interviewed	O
on	O
demographics	O
,	O
family	O
history	I:C0241889
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
,	O
occupational	O
and	O
environmental	O
toxicants	O
exposure	O
,	O
smoking	B:C1519386
status	I:C1519386
,	O
and	O
alcohol	O
consumption	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	B:C1550100
dosing	O
of	O
iron	O
,	O
copper	O
,	O
mercury	O
,	O
and	O
manganese	O
by	O
means	O
of	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	O
of	O
iron	B:C0337439
,	O
copper	O
,	O
mercury	O
,	O
and	O
manganese	O
by	O
means	O
of	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	O
of	O
iron	O
,	O
copper	B:C0373587
,	O
mercury	O
,	O
and	O
manganese	O
by	O
means	O
of	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	O
of	O
iron	O
,	O
copper	O
,	O
mercury	B:C0428257
,	O
and	O
manganese	O
by	O
means	O
of	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	O
of	O
iron	O
,	O
copper	O
,	O
mercury	O
,	O
and	O
manganese	B:C0373677
by	O
means	O
of	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	O
of	O
iron	O
,	O
copper	O
,	O
mercury	O
,	O
and	O
manganese	O
by	O
means	O
of	O
Inductively	B:C1553183
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

A	O
sample	O
of	O
65	O
patients	O
and	O
65	O
controls	O
also	O
underwent	O
serum	O
dosing	O
of	O
iron	O
,	O
copper	O
,	O
mercury	O
,	O
and	O
manganese	O
by	O
means	O
of	O
Inductively	O
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
(	O
Inductively	B:C1553183
Coupled	I:C1553183
-	I:C1553183
Plasma	I:C1553183
-	I:C1553183
Mass	I:C1553183
-	I:C1553183
Spectrometry	I:C1553183
)	O
.	O

Positive	B:C1446409
family	O
history	I:C0241889
,	O
toxicants	O
exposure	I:C0040537
,	O
non-current	O
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	O
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	O
factors	I:C0035648
in	O
our	O
population	O
.	O

Positive	O
family	B:C0241889
history	I:C0241889
,	O
toxicants	O
exposure	I:C0040537
,	O
non-current	O
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	O
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	O
factors	I:C0035648
in	O
our	O
population	O
.	O

Positive	O
family	O
history	I:C0241889
,	O
toxicants	B:C0040537
exposure	I:C0040537
,	O
non-current	O
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	O
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	O
factors	I:C0035648
in	O
our	O
population	O
.	O

Positive	O
family	O
history	I:C0241889
,	O
toxicants	O
exposure	I:C0040537
,	O
non-current	B:C3496610
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	O
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	O
factors	I:C0035648
in	O
our	O
population	O
.	O

Positive	O
family	O
history	I:C0241889
,	O
toxicants	O
exposure	I:C0040537
,	O
non-current	O
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	B:C0425322
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	O
factors	I:C0035648
in	O
our	O
population	O
.	O

Positive	O
family	O
history	I:C0241889
,	O
toxicants	O
exposure	I:C0040537
,	O
non-current	O
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	O
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	B:C0035648
factors	I:C0035648
in	O
our	O
population	O
.	O

Positive	O
family	O
history	I:C0241889
,	O
toxicants	O
exposure	I:C0040537
,	O
non-current	O
-	I:C3496610
smoker	I:C3496610
,	O
and	O
alcohol	O
nonconsumer	I:C0425322
status	I:C0425322
occurred	O
as	O
significant	O
risk	O
factors	I:C0035648
in	O
our	O
population	B:C1257890
.	O

The	O
number	O
of	O
concurring	B:C0035648
risk	I:C0035648
factors	I:C0035648
overlapping	O
in	O
the	O
same	O
subject	I:C0080105
impressively	O
increased	O
the	O
overall	O
risk	O
.	O

The	O
number	O
of	O
concurring	O
risk	I:C0035648
factors	I:C0035648
overlapping	O
in	O
the	O
same	B:C0080105
subject	I:C0080105
impressively	O
increased	O
the	O
overall	O
risk	O
.	O

No	O
significant	O
differences	O
were	O
measured	O
in	O
the	O
metal	B:C0025552
serum	O
levels	O
.	O

No	O
significant	O
differences	O
were	O
measured	O
in	O
the	O
metal	O
serum	B:C1550100
levels	O
.	O

Our	O
findings	B:C0243095
indicate	O
that	O
combination	O
of	O
three	O
to	O
four	O
concurrent	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
-	O
risk	O
factors	I:C0035648
defines	O
a	O
condition	O
"	O
at	O
risk	O
"	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

Our	O
findings	O
indicate	O
that	O
combination	O
of	O
three	O
to	O
four	O
concurrent	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
-	O
risk	O
factors	I:C0035648
defines	O
a	O
condition	O
"	O
at	O
risk	O
"	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

Our	O
findings	O
indicate	O
that	O
combination	O
of	O
three	O
to	O
four	O
concurrent	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
-	O
risk	B:C0035648
factors	I:C0035648
defines	O
a	O
condition	O
"	O
at	O
risk	O
"	O
of	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
.	O

Our	O
findings	O
indicate	O
that	O
combination	O
of	O
three	O
to	O
four	O
concurrent	O
Parkinson	O
's	I:C0030567
Disease	I:C0030567
-	O
risk	O
factors	I:C0035648
defines	O
a	O
condition	O
"	O
at	O
risk	O
"	O
of	O
Parkinson	B:C0030567
's	I:C0030567
Disease	I:C0030567
.	O

A	O
simple	O
stratification	B:C1514983
,	O
based	O
on	O
these	O
questionnaires	O
,	O
might	O
be	O
of	O
help	O
in	O
identifying	O
subjects	I:C0949543
suitable	O
for	O
neuroprotective	O
strategies	O
.	O

A	O
simple	O
stratification	O
,	O
based	O
on	O
these	O
questionnaires	B:C0034394
,	O
might	O
be	O
of	O
help	O
in	O
identifying	O
subjects	I:C0949543
suitable	O
for	O
neuroprotective	O
strategies	O
.	O

A	O
simple	O
stratification	O
,	O
based	O
on	O
these	O
questionnaires	O
,	O
might	O
be	O
of	O
help	O
in	O
identifying	B:C0949543
subjects	I:C0949543
suitable	O
for	O
neuroprotective	O
strategies	O
.	O

